Related Experiment Video
Updated: Dec 21, 2025
06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.7K
Targeting RGS4 Ablates Glioblastoma Proliferation
Maheedhara R Guda1, Kiran K Velpula1,2,3, Swapna Asuthkar1
1Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA.
International Journal of Molecular Sciences
|May 13, 2020
Summary
Silencing Regulators of G-protein signaling 4 (RGS4) inhibits growth, invasion, and migration of Glioblastoma (GBM) cancer stem cells. This finding highlights RGS4 as a potential therapeutic target for treating aggressive brain tumors like GBM.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Stem Cell Research
Background:
- Glioblastoma (GBM) presents a significant challenge in adult primary brain tumors, with poor prognosis due to cellular heterogeneity and cancer stem cell populations.
- G-protein-coupled receptors (GPCRs) are crucial in cellular signaling, and Regulators of G-protein signaling 4 (RGS4) act as negative regulators, with elevated RGS4 linked to various cancers.
- High RGS4 expression correlates with poor patient survival in GBM, indicating its potential role in tumor progression.
Purpose of the Study:
- To investigate the therapeutic potential of silencing RGS4 in Glioblastoma (GBM) and its impact on glioma cancer stem cell (GSC) behavior.
- To determine the effect of RGS4 inhibition on GSC growth, invasion, migration, and apoptosis.
- To validate RGS4 expression levels in GBM patient samples and correlate them with clinical data.
Main Methods:
- Utilized CRISPR-Cas9 technology to create RGS4 knockout (ko-RGS4) GSCs.
- Performed RNA sequencing and gelatin zymography to assess changes in gene expression and matrix metalloproteinase-2 (MMP2) activity.
- Employed Matrigel plug, wound healing, and human apoptosis array assays to evaluate GSC invasion, migration, and apoptosis.
Main Results:
- Silencing RGS4 significantly inhibited GSC growth, invasion, and migration.
- RNA sequencing revealed decreased expression of invasion and migration markers, notably MMP2, in ko-RGS4 cells.
- Gelatin zymography confirmed reduced MMP2 activity in ko-RGS4 samples, with functional assays demonstrating diminished invasive and migratory capacities and increased apoptosis.
Conclusions:
- RGS4 plays a critical role in regulating key cellular functions in GBM, including invasion and migration.
- Silencing RGS4 demonstrates significant anti-tumor effects on GSCs, suggesting its potential as a therapeutic target.
- Targeting RGS4 offers a promising strategy for developing novel treatments for Glioblastoma.
